Skip to main content

All Miami Cancer Institute

Submissions from 2023 2023

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results, Guenther Koehne

Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Brain Metastases from Non-Small Cell Lung Cancer: An International Multicenter Study of 395 Patients, Ahmad Ozair, Atulya Khosla, and Manmeet Ahluwalia

Integration and dosimetric validation of a dynamic collimation system for pencil beam scanning proton therapy, Alonso Gutiérrez

Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma, Manmeet Ahluwalia

Single-fraction radiosurgery outcomes for large vestibular schwannomas in the upfront or post-surgical setting: a systematic review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines, Rupesh Kotecha

Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda

Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma, Minesh Mehta

Artificial intelligence in laparoscopic simulation: a promising future for large-scale automated evaluations, Domenech Asbun

Ablative 5-fraction CT- versus MR-guided pancreatic SBRT: dosimetric effects of interfraction anatomic change, Michael Chuong, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Diane Alvarez, Nema Bassiri-Gharb, Alonso Gutierrez, James McCulloch, Kathryn Mittauer, Nicole McAllister, Ashley Fellows, Amy Rzepczynski, and Will Deere

A comparative evaluation of different radiosurgery management strategies for large brain metastases: What is the optimal treatment paradigm?, Tugce Kutuk, Sreenija Yarlagadda, Ranjini Tolakanahalli, Matthew Hall, Anshul Saxena, Alonso La Rosa de los Rios, Martin Tom, D Jay Wieczorek, Cecilia Lee, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, Rupesh Kotecha, and Mukesh Roy

Advancing Beyond the Hippocampus to Improve Cognition for Patients with Brain Metastases: An Initial Report of a Phase 2 Trial Examining Memory-Avoidance Whole Brain Radiotherapy, Rupesh Kotecha

Characterization of Large Brain Metastases with 18F-Fluciclovine PET/CT Treated with Staged Stereotactic Radiosurgery (SSRS): Phase 1 Proof-of-Concept Interim Analysis, Alonso La Rosa de los Rios, Surya Chundru, Martin Tom, Tugce Kutuk, D Jay Wieczorek, Muni Rubens, Ranjini Tolakanahalli, Michael McDermott, Matthew Hall, Alonso Gutierrez, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

Dosimetric evaluation of a novel non-metallic dual port expander for proton therapy, Joseph Panoff, Zachary Fellows, Andrew Wroe, and Kristen McConnell

Healthcare expenditure trends among adult stroke patients in the United States, 2011-2020, Venkataraghavan Ramamoorthy, Mukesh Roy, Anshul Saxena, Md Ashfaq Ahmed, Zhenwei Zhang, Peter McGranaghan, Michael McDermott, Felipe De Los Rios La Rosa, and Muni Rubens

Heatmaps to Assess Tumor Motion Probability with MRcine in Head and Neck Cancer, Yonatan Weiss

Implementation Outcomes of Strategies to Promote Short-Course Radiation for Nonspine Bone Metastases in an Academic-Community Partnership – Survey Results from the ALIGNMENT Trial, Joseph Panoff

Integration of an APP-based Neurocognitive Evaluation Program into Stereotactic Radiosurgery Practice: Outcomes and Patient Survey Analysis from a Prospective Observational Study, Tugce Kutuk, Cecilia Lee, Yazmin Odia, Alonso La Rosa de los Rios, Matthew Hall, Haley Appel, Michael McDermott, Manmeet Ahluwalia, Minesh Mehta, and Rupesh Kotecha

"Multi-institutional Experience of Definitive Proton Therapy for Osteosarcoma Acute Toxicities and Outcomes", Keitrina Mair, Katherine Von Werne, Noah Kalman, Michael Chuong, Matthew Hall, and Robert Press

Multi-institutional Experience of Proton Therapy for Rhabdomyosarcoma and Ewing Sarcoma in the Proton Collaborative Group (PCG) Prospective Registry, Katherine Von Werne, Keitrina Mair, Noah Kalman, and Robert Press

Outcomes of MR-guided Stereotactic Body Radiotherapy (MRgSBRT) for adrenal metastases: A multi-institutional pooled analysis, Rupesh Kotecha and Tugce Kutuk

Patterns of locoregional failure after ablative 5-fraction stereotactic MR-guided on-table adaptive radiation therapy for pancreatic cancer, Michael Chuong, Nicole McAllister, Surya Chundru, Robert Herrera, Adeel Kaiser, Matthew Hall, Rupesh Kotecha, Kathryn Mittauer, Diane Alvarez, James McCulloch, Nema Bassiri-Gharb, Alonso Gutierrez, Nicolas Carvallo, and Jason Extein

Phase II Trial of Stereotactic MR-guided On-table Adaptive Radiation Therapy for Borderline or Locally Advanced Pacreatic Cancer: Updated Safety & Efficacy Outcomes, Michael Chuong and Kathryn Mittauer

Retrospective Assessment of Surface Imaging Set up Accuracy for Intensity Modulated Proton Therapy of Comprehensive Breast Irradiation, Daniel Cho, Alonso La Rosa de los Rios, and Andrew Wroe

Stereotactic Radiosurgery for Small Intact Brain Metastasis: A Comparative Evaluation Between 3 Single Fraction Prescription Doses, Sreenija Yarlagadda, Tugce Kutuk, Anshul Saxena, Mukesh Roy, Ranjini Tolakanahalli, Haley Appel, Alonso La Rosa de los Rios, Martin Tom, Matthew Hall, D Jay Wieczorek, Michael McDermott, Manmeet Ahluwalia, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha